Literature DB >> 25203153

Age and ethnicity in cirrhosis.

Krishna C Sajja1, Desh P Mohan, Don C Rockey.   

Abstract

BACKGROUND: Cirrhosis is diagnosed in patients of all ages and is the end result of many different diseases. The aim of this study was to characterize clinical and ethnic features of adult patients who were admitted to the hospital at different (young/old) ages and examine associations between age and ethnicity within these groups.
METHODS: In this retrospective analysis of a diverse cohort of 2017 patients with a clinical diagnosis of cirrhosis between January 2001 and December 2011, we focused on age, ethnicity, and outcome of patients with cirrhosis.
RESULTS: We identified 219 patients younger than the age of 40 years, including 87 (11%) of 802 white, 31 (6%) of 550 African American, and 89 (16%) of 550 Hispanic patients (P < 0.001). Ethnicity and causes of cirrhosis were found to have a significant correlation with age. Overall, Hispanic and white patients together were more than twice as likely to be diagnosed with cirrhosis at an age younger than 40 years compared with African American patients (P < 0.001). Autoimmune hepatitis caused cirrhosis at a younger age regardless of ethnicity (P < 0.001), whereas cryptogenic/nonalcoholic fatty liver disease/nonalcoholic steatohepatitis was more likely identified at an older age (P = 0.008). African American patients with cirrhosis due to either alcohol or hepatitis C virus were older than Hispanic (P < 0.001 and P = 0.003, respectively) and white patients (P < 0.001 and P < 0.001, respectively) at presentation. Finally, younger patients admitted with cirrhosis had a higher in-hospital mortality rate (P < 0.001).
CONCLUSIONS: The data suggest an association between ethnicity and age of cirrhosis diagnosis, both overall and in patients with certain cirrhosis etiologies. This work raises the possibility of an ethnic and/or genetic basis for cirrhosis.

Entities:  

Mesh:

Year:  2014        PMID: 25203153      PMCID: PMC4172494          DOI: 10.1097/JIM.0000000000000106

Source DB:  PubMed          Journal:  J Investig Med        ISSN: 1081-5589            Impact factor:   2.895


  41 in total

1.  More advanced hepatic fibrosis in hispanics with chronic hepatitis C infection: role of patient demographics, hepatic necroinflammation, and steatosis.

Authors:  Sumita Verma; Maurizio Bonacini; Sugantha Govindarajan; Gary Kanel; Karen L Lindsay; Allan Redeker
Journal:  Am J Gastroenterol       Date:  2006-06-22       Impact factor: 10.864

2.  Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma.

Authors:  Jean S Campbell; Steven D Hughes; Debra G Gilbertson; Thomas E Palmer; Matthew S Holdren; Aaron C Haran; Melissa M Odell; Renay L Bauer; Hong-Ping Ren; Harald S Haugen; Matthew M Yeh; Nelson Fausto
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-22       Impact factor: 11.205

3.  Hepatic fibrosis 2006: report of the Third AASLD Single Topic Conference.

Authors:  Scott L Friedman; Don C Rockey; D Montgomery Bissell
Journal:  Hepatology       Date:  2007-01       Impact factor: 17.425

4.  Chronic liver disease is triggered by taurine transporter knockout in the mouse.

Authors:  Ulrich Warskulat; Elena Borsch; Roland Reinehr; Birgit Heller-Stilb; Irmhild Mönnighoff; Darius Buchczyk; Markus Donner; Ulrich Flögel; Günther Kappert; Sibylle Soboll; Sandra Beer; Klaus Pfeffer; Hanns-Ulrich Marschall; Marcus Gabrielsen; Mahmood Amiry-Moghaddam; Ole Petter Ottersen; Hans Peter Dienes; Dieter Häussinger
Journal:  FASEB J       Date:  2006-01-18       Impact factor: 5.191

5.  Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C.

Authors:  Hongjin Huang; Mitchell L Shiffman; Ramsey C Cheung; Thomas J Layden; Scott Friedman; Olivia T Abar; Linda Yee; Anand P Chokkalingam; Steven J Schrodi; Jason Chan; Joseph J Catanese; Diane U Leong; David Ross; Xiaolan Hu; Alexander Monto; Linda B McAllister; Samuel Broder; Thomas White; John J Sninsky; Teresa L Wright
Journal:  Gastroenterology       Date:  2006-03-06       Impact factor: 22.682

6.  Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice.

Authors:  Piotr Czochra; Borut Klopcic; Erik Meyer; Johannes Herkel; Jose Francisco Garcia-Lazaro; Florian Thieringer; Peter Schirmacher; Stefan Biesterfeld; Peter R Galle; Ansgar W Lohse; Stephan Kanzler
Journal:  J Hepatol       Date:  2006-05-30       Impact factor: 25.083

7.  HIV, age, and the severity of hepatitis C virus-related liver disease: a cohort study.

Authors:  Gregory D Kirk; Shruti H Mehta; Jacquie Astemborski; Noya Galai; Jonathan Washington; Yvonne Higgins; Ashwin Balagopal; David L Thomas
Journal:  Ann Intern Med       Date:  2013-05-07       Impact factor: 25.391

Review 8.  Genetics of nonalcoholic Fatty liver disease: an overview.

Authors:  Jharna Puppala; Siva Prasad Siddapuram; Jyothy Akka; Anjana Munshi
Journal:  J Genet Genomics       Date:  2012-12-26       Impact factor: 4.275

9.  Lysophosphatidic acid aberrancies and hepatocellular carcinoma: studies in the MDR2 gene knockout mouse.

Authors:  Nicholas Skill; Jianmin Wu; Yan Xu; Zheng Zhao; Mary Maluccio
Journal:  Cancer Invest       Date:  2013-02       Impact factor: 2.176

10.  Up-regulation of RACK1 by TGF-β1 promotes hepatic fibrosis in mice.

Authors:  Dongwei Jia; Fangfang Duan; Peike Peng; Linlin Sun; Xiaojuan Liu; Lan Wang; Weicheng Wu; Yuanyuan Ruan; Jianxin Gu
Journal:  PLoS One       Date:  2013-03-29       Impact factor: 3.240

View more
  11 in total

1.  Ten-year trends and prediction model of 30-day inpatient mortality for alcoholic hepatitis in the United States.

Authors:  Hassam Ali; Rahul Pamarthy; Nicole Leigh Bolick; Muhammad Fahd Farooq
Journal:  Ann Gastroenterol       Date:  2022-05-12

2.  Race and Gradient Difference Are Associated with Increased Risk of Hepatic Encephalopathy Hospital Admission After Transjugular Intrahepatic Portosystemic Shunt Placement.

Authors:  Michael W Rowley; Myunghan Choi; Steve Chen; Kevin Hirsch; Anil B Seetharam
Journal:  J Clin Exp Hepatol       Date:  2017-12-30

3.  KIR2DL2/S2 and KIR2DS5 in alcoholic cirrhotic patients undergoing liver transplantation.

Authors:  Isabel Legaz; Jose Miguel Bolarín; Elena Navarro; Jose Antonio Campillo; Rosa Moya; María Dolores Pérez-Cárceles; Aurelio Luna; Eduardo Osuna; Manuel Miras; Manuel Muro; Alfredo Minguela; Rocio Alvarez López
Journal:  Arch Med Sci       Date:  2019-04-09       Impact factor: 3.318

4.  Prevalence and Clinical Characteristics of NAFLD in Chronic Liver Disease Patients from King Abdulaziz University Hospital, Jeddah.

Authors:  Hind Ibrahim Fallatah; Ammar Al-Dabbagh; Mohammead T Hiejazi; Sulaiman A A Hanbazazah; Ali O Hussein; Majed A Al-Sahafi; Hisham O Akbar
Journal:  Saudi J Med Med Sci       Date:  2020-04-17

5.  Age-related differences in clinical characteristics of invasive group G streptococcal infection: Comparison with group A and group B streptococcal infections.

Authors:  Yoshihiro Fujiya; Kayoko Hayakawa; Yoshiaki Gu; Kei Yamamoto; Momoko Mawatari; Satoshi Kutsuna; Nozomi Takeshita; Yasuyuki Kato; Shuzo Kanagawa; Norio Ohmagari
Journal:  PLoS One       Date:  2019-03-07       Impact factor: 3.240

6.  NGF (-198C > T, Ala35Val) and p75NTR (Ser205Leu) gene mutations are associated with liver function in different histopathological profiles of the patients with chronic viral hepatitis in the Brazilian Amazon.

Authors:  Leonn Mendes Soares Pereira; Ednelza da Silva Graça Amoras; Simone Regina Souza da Silva Conde; Sâmia Demachki; Eduardo José Melo Dos Santos; Sandra Souza Lima; Ricardo Ishak; Antonio Carlos Rosário Vallinoto
Journal:  Mol Med       Date:  2020-01-29       Impact factor: 6.354

7.  Cirrhosis and Advanced Fibrosis in Hispanics in Texas: The Dominant Contribution of Central Obesity.

Authors:  Jingjing Jiao; Gordon P Watt; MinJae Lee; Mohammad H Rahbar; Kristina P Vatcheva; Jen-Jung Pan; Joseph B McCormick; Susan P Fisher-Hoch; Michael B Fallon; Laura Beretta
Journal:  PLoS One       Date:  2016-03-07       Impact factor: 3.240

8.  Accuracy of Noninvasive Fibrosis Scoring Systems in African American and White Patients With Nonalcoholic Fatty Liver Disease.

Authors:  Hemnishil K Marella; Yala Kirthi Reddy; Yu Jiang; Surosree Ganguli; Pradeep S B Podila; Peter D Snell; Alexander J Kovalic; George Cholankeril; Ashwani K Singal; Satheesh Nair; Benedict Maliakkal; Sanjaya K Satapathy
Journal:  Clin Transl Gastroenterol       Date:  2020-04       Impact factor: 4.396

9.  Predictors of Three-month Hospital Readmissions and Mortality in Patients with Cirrhosis of Liver.

Authors:  Anurag Lavekar; Dhananjay Raje; Aarsha Sadar; Tanuja Manohar; Kavutharapu Sri Manjari; Pradeep T Satyanarayana
Journal:  Euroasian J Hepatogastroenterol       Date:  2019 Jul-Dec

10.  Compound Sarcopenia in Hospitalized Patients with Cirrhosis Worsens Outcomes with Increasing Age.

Authors:  Nicole Welch; Amy Attaway; Annette Bellar; Hayder Alkhafaji; Adil Vural; Srinivasan Dasarathy
Journal:  Nutrients       Date:  2021-02-18       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.